Stock & Company Details
AN2 Therapeutics Inc $ANTX
Price:
46,691,331
36M
$177M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Services
ANTX technical indicators
Latest AN2 Therapeutics Inc (ANTX) technical indicators as of 2026-07-27: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
56.77 0.5%
MACD:
0.08 7.2%
SMA 50:
$4.64 0.3%
SMA 200:
$2.73 0.7%
EMA 20:
$4.77 0.4%
Bollinger Bands:
5.12 / 4.28
Stochastic:
72.46 1.6%
ADX 14:
12.94 0.9%
ATR 14:
0.37 4.7%
CCI 20:
82.06 1.8%
OBV:
54.70M 0.1%
ROC 12:
6.48% 44.0%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
Finance Bot
Ask your questions
Start by typing a question below.
